VINDHYA DATA SCIENCE INC.
Medtech · Private
BIOCLIN—a clinical software platform that analyzes RNAseq data on-the-fly, runs machine learning models to compute gene signature scores, and displays results in a user interface to support patient se
- Grants
- $405K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $653K
- 4 awards · Health and Human S
- #362 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Rapid Response For The Association Between Outcomes And Dental Services In Persons With Diabetes Mellitus And Chronic Kidney Disease | $139,117 | |
| Federal grant | Department of Health and Human Services · Phase I · BIOCLIN: A precision medicine platform to support biomarker-driven clinical trials | $175,507 | |
| Federal contract | Department of Health and Human Services · The Association Between Outcomes And Dental Services In Persons With Autoimmune Disease Treated With Biologics | $172,445 | |
| Federal contract | Department of Health and Human Services · Association Between Outcomes And Dental Services In Persons With Hiv And Substance Abuse Disorder. | $171,212 | |
| Federal contract | Department of Health and Human Services · Dental Care For Persons Receiving Treatments That Cause Osteonecrosis Of The Jaw | $170,463 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing entrepreneurial skills for the BIOCLIN software platform to support biomarker clinical trials | $54,992 | |
| Federal grant | Department of Health and Human Services · Phase I · BIOCLIN: A precision medicine platform to support biomarker-driven clinical trials | $174,107 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 359 | INVIVOSCIENCES, INC. | $679K | — |
| 360 | Sonica LLC | $656K | — |
| 361 | Beta Bionics, Inc. | $654K | $222M |
| 362 | VINDHYA DATA SCIENCE INC. | $653K | — |
| 363 | Potsdam Sensors LLC | $647K | — |
| 364 | X-BIOMEDICAL INC | $646K | $425K |
| 365 | Starr Life Sciences Corp. | $642K | $4.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.